![(2,3,4-trihydroxy-5-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl)methyl…](https://static.cymitquimica.com/cas-image/405063-234-trihydroxy-5-456-trihydroxy-3-hydroxymethyl-cyclohex-2-en-1-yl-amino-cyclohexyl-methyl-hexopyranoside.png)
CAS: 12650-67-8 - (2,3,4-trihydroxy-5-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl)methyl hexopyranoside
Formula:C20H35NO13
InChI:InChI=1/C20H35NO13/c22-3-6-1-8(13(26)16(29)11(6)24)21-9-2-7(12(25)17(30)14(9)27)5-33-20-19(32)18(31)15(28)10(4-23)34-20/h1,7-32H,2-5H2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Validamycin D REF: 4Z-V-046003CAS: 12650-67-8 | - - - | To inquire | Mon 29 Jul 24 |
 | Validamycin D REF: TR-V943443CAS: 12650-67-8 | - - - | 22,540.00 € | Tue 03 Sep 24 |
 | Validamycin D REF: 3D-MAA65067CAS: 12650-67-8 | Min. 95% | To inquire | Tue 03 Sep 24 |
Ref: 4Z-V-046003
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 29 Jul 2024
Validamycin D
Controlled ProductCAS:12650-67-8
Formula:
C20H35NO13
Color and Shape:
Neat
Molecular weight:
497.491
Ref: TR-V943443
| 50mg | 22,540.00 € |
Estimated delivery in United States, on Tuesday 3 Sep 2024
Validamycin D
CAS:12650-67-8
Validamycin D is an inhibitor of kinases that has shown potential for use in cancer …
Formula:
C20H35NO13
Purity:
Min. 95%
Molecular weight:
497.5 g/mol
Ref: 3D-MAA65067
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 3 Sep 2024
